+
Site Tour

Webinar 2022: Management of aortic and mitral valve disease

Torsten Doenst et al. Focus on the management of aortic and mitral valve disease with future treatment in mind. Including quality of life, preserving the long-treatment path, and the role of porcine tissue valves during a recorded webinar.

Related Videos

SAFETY IS A JOURNEY | J. Van der Heyden & C. Besler

EuroPCR 2022: Mitral replacement

PCRLV 2022: TAVI Hemodynamic performance

EuroPCR 2022: Tendyne™

M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks

EuroPCR 2023: Defining the future

AV VALVES 2023: MR – MAC

TAVI Summit 2023: Morphology

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

PCRLV 2021: Transcatheter mitral valve replacement

Data Summary PFO closure in patients > 60 Years

Tendyne™: 6-Year Outcomes

EuroEcho 2021: MR Treatment (Evidence)

CONNEXT


LIVE
RELATED EVENTS

Now you've got Navitor

TAVI Summit - TAVR in bicuspid

Navigating the Anatomy | Mitral focus

AV VALVES 2023: Staged, Concomitant

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline